中文版 | English

Home

news

news

Index > news

Our product passed the U.S. FDA site inspection2013-5-28 10:09:09

From April 15 to 18, 2013, the U.S. FDA officials site inspected our products: Tobramycin, Mycophenolic acid, Amikacin for a period of four days on GMP compliance. At the summary of the meeting, prosecutors affirmed that Daxin Pharmaceutical had done a good job on GMP compliance, and they did not found any non-compliance events and phenomena. And all agreed that Chongqing Daxin passed the inspection.

Pre page:No data
抖音黄版本下载_抖音黄版本app下载安卓版